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ABSTRACT
Objectives: To examine the usefulness of smoothelin - a new immunohistochemical (IHC) marker 
that is expressed predominantly in visceral smooth muscle - in recognizing muscularis propria 
(MP) in transurethral resection (TUR) and matched cystectomy specimens and to compare the 
pattern of its expression in muscularis mucosae (MM) and MP in radical cystectomy specimens.
Methods: IHC staining for smoothelin was performed in 49 cases of urothelial carcinoma removed 
by radical cystectomy (16 had undergone TUR before the cystectomy).
Results: In cystectomy specimens, smoothelin staining in the MP was strong (+3), moderate (+2) 
and weak (+1) in 49%, 44.9% and 6.1% of cases, respectively, whereas smoothelin positivity in 
the MM was absent and weak in 77.6% and 22.4% of cases, respectively. In TUR specimens, 
smoothelin immunoreactivity was moderate to strong in 68.8% and weak in 6.3% of cases and all 
of them proved to have MP invasion in cystectomy specimens. 
Conclusion: Smoothelin is a useful marker for the detection of MP in TUR specimens. Moderate 
to strong smoothelin staining of the muscles included in TUR specimens and split by the tumor is 
a sign of MP invasion. It may be useful in cancer staging and treatment decision making.
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INTRODUCTION                                                    
Bladder cancer is among the top 10 
causes of cancer-related deaths in the 
USA1. In Egypt, it is the most commonly 
diagnosed malignancy2. Tumor stage is the 
most important prognostic factor in bladder 
carcinoma. Accurate staging remains a critical 
task that allows for appropriate prognostic 
and therapeutic stratification of patients. 
Recognition of the depth of invasion by 
carcinoma is a vital determinant of subsequent 
therapy and prognosis. In the urinary bladder, 
urothelial carcinoma limited to the lamina 
propria is staged as pT1 and involvement 
of muscularis propria (MP) is staged as at 
least pT23. It is now widely known that an 
inconsistent layer of muscularis mucosae 
(MM) muscle exists in the lamina propria, 
which can mimic the MP, particularly when 
hyperplastic. This makes staging extremely 
challenging in small, un-oriented or highly 
cauterized specimens. Also the presence 
of a desmoplastic stromal response rich in 
fibroblasts may mimic muscle bundles4–6.  
Smoothelin is a smooth muscle-specific 
cytoskeletal protein exclusively found 
in differentiated smooth muscle cells. 
This contrasts with other smooth muscle 
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Immunohistochemistry (IHC)
IHC was performed according to the 
manufacturer’s protocol. Tissue sections 
(4-μm thick) of formalin-fixed, paraffin-
embedded specimens were deparaffinized, 
rehydrated in graded alcohol and transferred 
to phosphate buffered saline (PBS; pH 7.6). 
The slides were rinsed twice with PBS, then 
endogenous peroxidase was blocked by the 
use of 3% hydrogen peroxide in methanol 
for 5 minutes and antigen retrieved using 
microwave at 700W for 20 minutes in citrate 
buffer. 
After cooling, the slides were washed 
three times with PBS. The slides were then 
incubated overnight at room temperature 
with primary antibody for smoothelin 
(Biocare Medical CA, USA) at a dilution of 
1:100. The slides were then rinsed three times 
with PBS and incubated for 15 minutes at 
room temperature with the primary antibody 
enhancer (Thermo Scientific, Fremont, USA). 
The slides were rinsed three times with PBS 
and incubated for 15 minutes with HRP 
polymer (Thermo Scientific, Fremont, USA). 
The sections were then washed three times 
with PBS and diamino benzidine (DAB) was 
applied for 5 minutes at room temperature. 
The slides were then rinsed in distilled water, 
counterstained with Mayer’s hematoxylin, 
dehydrated and mounted.  
The interpretation of immunoreactivity 
was performed in a semiquantitative manner 
by analyzing the extent of the staining posi-
proteins (eg, h-caldesmon, [alpha]-smooth 
muscle actin, desmin, smooth muscle 
myosin) which are expressed in proliferative 
(early) stages of smooth muscle development 
and occasionally in other cell types (striated 
muscle, myofibroblasts, myoepithelial cells, 
pericytes). Smoothelin has been shown 
to be expressed predominantly in visceral 
smooth muscle and to a lesser extent in 
vascular smooth muscle7. Few previous 
reports estimate the difference in smoothelin 
expression in transurethral resection (TUR) 
or cystectomy specimens8, 9. 
The aim of this study was to examine 
the capability of smoothelin in recognizing 
muscularis propria in TUR specimens and 
matched cystectomy specimen and to compare 
the pattern of its expression in MM and MP 
in radical cystectomy specimens.
PATIENTS AND METHODS                                     
The Specimens
This study consisted of Group 1: 6 cases of 
TUR biopsy with matched radical cystectomy 
specimens of the same patients and Group 2: 
33 cystectomy specimens with prominent 
MM in hematoxylin and eosin (H&E) stained 
sections. All specimens were obtained from 
the Urology Department, Assiut University 
Hospital, Faculty of Medicine, Assiut 
University and examined in the Departments 
of Pathology, Faculties of Medicine, Assiut 
and Sohag Universities from January 
2009 to June 2009.
Fig. 1: Immunostaining of smoothelin in MM of 
cystectomy specimen showing weak positivity 
(IHC, original magnification x100).
Fig. 2: Smoothelin expression in MP invaded by nests 
of tumor cells showing strong smoothelin expression 
(IHC, original magnification x200).
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tivity of the muscle cells. For MP, the inner 
muscle layer or muscle bundles bordering 
the lamina propria were selected to evaluate 
staining of MP bundles of the inner half of 
the bladder wall, because these muscle bun-
dles were most likely to be included in TUR 
specimens and could be confidently evalua-
ted with respect to the overlying urothelium 
in all available specimens. Staining intensity 
was recorded as negative, weak, moderate or 
strong. The staining score was evaluated as 
follows: 0 or negative, +1 or weak, +2 or mo-
derate and +3 or strong positivity. Represen-
tative sections were used for evaluation by 
H&E and IHC. MM and MP were evaluated 
in H&E and corresponding smoothelin stai-
ned slides.
RESULTS                                                            
In cystectomy specimens, 38 of 49 cases 
had definite MM bundles and in 11 cases it 
was not well identified and only showed a 
few spindle cells in the lamina propria. 
Smoothelin expression in cystectomy 
specimens
IHC staining for smoothelin in bladder 
MM, MP and blood vessels in cystectomy 
specimens is summarized in Table 1.
MM muscles predominantly had ab-
sent or weak smoothelin staining in 77.6% 
and 22.4% of cases, respectively (Fig. 1) 
and none had moderate or strong staining. 
On the other hand, MP muscles predomi-
nantly had moderate or strong smoothe-
lin staining in 49% and 44.9% of cases, 
respectively (Fig. 2).
Only 3 (6.1%) cases showed a 
weak smoothelin staining pattern in 
MP. Desmoplastic reaction to invasive 
carcinoma always stained negatively. 
Considering moderate and strong smoothelin 
immunostaining as the cut-off value for the 
presence of MP, smoothelin expression was 
93.9% sensitive and 100% specific for MP 
(vs. MM) in cystectomy specimens.
The smooth muscles of vessels showed 
either negative or weakly positive smoothelin 
reactivity especially in large caliber arteries of 
MP in 44.9% and 53.1% of cases, respectively 
and only one case (2%) showed moderate 
smoothelin staining. 
Smoothelin expression in TUR specimens 
is shown in Table 2
In TUR specimens 11/16 (68.8%) of 
the muscles showed moderate to strong 
smoothelin expression while 1/16 (6.3%) 
showed weak expression as shown in 
table 2. Cystectomy specimens of these 
patients proved muscle invasion and also 
showed smoothelin positivity. The blood 
vessels of vascular plexuses in the lamina 
propria were consistently negative or 
weakly stained.








22/49 (44.9%) 0/49 (0%)  38/49 (77.6%) 0
26/49 (53.1%) 3/49 (6.1%) 11/49 (22.4%) +1
1/49 (2%) 22/49 (44.9%) 0/49 (0%) +2
0/49 (0%) 24/49 (49%) 0/49 (0%) +3
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DISCUSSION                                                             
Tumor stage is the most important pro-
gnostic factor in bladder carcinoma and the 
cornerstone of the pathologic tumor (pT) 
categories is evaluating the depth of car-
cinoma invasion in the bladder wall. The 
urinary bladder MP serves as an important 
anatomic landmark in the assessment of the 
depth of invasive carcinoma and is most of-
ten the critical dividing line between conser-
vative and aggressive management in pa-
tients with bladder cancer. Involvement of 
the MP in a TUR specimen would stage the 
urothelial carcinoma as “deeply” invasive 
(at least pT2) indicating the need for cystec-
tomy5. Thus, accurate identification of the 
MP by the pathologist is important in every 
TUR biopsy. Determination of the type of 
muscles (MM versus MP) invaded by car-
cinoma can occasionally be difficult, due 
to small sample size, tissue distortion, caute-
ry artefact, poor orientation, fibrosis, inflam-
mation or hypertrophy of the normally thin, 
wispy MM1,5. 
A few studies have reported that 
smoothelin immunoreactivity was useful 
in the discrimination between MM and MP 
in TUR and cystectomy specimens with 
unequivocal morphological findings8,9.In 
this study, we provide further demonstration 
that smoothelin positivity can serve as 
an adjuvant tool in the evaluation of MP 
invasion by bladder carcinoma in diagnostic 
bladder biopsy.  
Paner et al found that MM typically 
showed absent or weak positivity for smoo-
thelin in 88% of cases and MP showed strong 
positivity in 86% of cases8. In the current 
study we found that 93.9% of MP showed 
moderate or strong positivity for smoothe-
lin; whereas 100% of MM showed no or 
weak positivity. 
MP showed moderate or strong 
smoothelin immunoreactivity in 46/49 
(93.9%) and weak positivity in 3/49 (6.1%) 
of cystectomy specimens.  This means that 
moderate to strong smoothelin expression 
was 93.9% sensitive and 100% specific for 
MP detection in cystectomy specimens.  Also, 
MP showed moderate or strong smoothelin 
immunoreactivity in 11/16 (68.8%) and weak 
reactivity in 1/16 (6.3%) TUR specimens. 
As all these cases were shown to have MP 
invasion in cystectomy specimens, smoothelin 
could be used as a marker of MP invasion in 
TUR biopsies.
In TUR specimens included in the 
present study, smoothelin immunoreactivity 
confirmed the presence of MP in 68.8% 
of cases. This highlights the importance 
of smoothelin immunostaining, since the 
recognition of MP in small TUR specimens 
may obviate the need to perform a restaging 
TUR, especially in the case of high-grade 
invasive urothelial carcinomas. These finding 
were consistent with a recent report by 
Bovio et al 201010. 
Although smoothelin reactivity is useful 
as adjunct to light microscopic evaluation, it 
should not be used as the sole determinant of 
muscle invasion, as we have three cases in 
which MP showed weak smoothelin reacti-
vity in cystectomy specimens and one case of 
weak positivity in TUR biopsies. However, 
in these cases MM and blood vessels showed 
smoothelin negativity. 
Myofibroblasts  are distinct cells with cha-
racteristics of both smooth muscle cells and 
fibroblasts. They are thought to play a critical 
role in inflammation, repair and neoplasia11. 
Especially in cases of schistosoma-associated 
bladder cancer, differentiation between the 
characteristic prominent desmoplastic reac-
tion and muscles split by tumor cells is very 
important. In the current study, desmoplastic 
reaction to invasive carcinoma and reaction 










Table 2: Smoothelin expression in bladder MM and MP in 
TUR biopsies.
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for smoothelin reactivity, whereas smoothe-
lin was expressed at a similar level in MM 
and blood vessels of the lamina propria.
The reactivity of the medium-sized 
vessels is related to the expression of 
different isoforms of smoothelin: smoothelin 
A in contractile visceral smooth muscle and 
smoothelin B in vascular smooth muscle. 
The smoothelin antibody clone R4A used in 
this study binds to both visceral and vascular 
isoforms of smoothelin, accounting for the 
reactivity observed at these sites. This finding 
is consistent with a recent report by Bovio 
and colleagues who suggest using this finding 
as internal control for IHC, since vessels 
are present in nearly all specimens of non-
superficial bladder cancer10.
CONCLUSIONS                                                      
Our data confirm the value of moderate 
to strong smoothelin immunostaining 
to distinguish between MP, MM and 
desmoplastic reactions, thereby facilitating 
appropriate pathologic stage designation in 
often challenging TUR specimens.
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